Tamoxifen to treat male pubertal gynaecomastia
Pubertal gynaecomastia affects up to 70% of male adolescents, with the highest prevalence occurring at 14 years of age. While spontaneous regression occurs in 90% of cases within three years, until then, symptoms of mastodynia and psychological distress are preva-lent in some patients prior to surgi...
Spremljeno u:
| Glavni autor: | |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wolters Kluwer Medknow Publications
2015-07-01
|
| Serija: | International Journal of Pediatrics & Adolescent Medicine |
| Teme: | |
| Online pristup: | https://journals.lww.com/10.1016/j.ijpam.2015.09.002 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|